Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Condition(s):CancerLast Updated:June 11, 2010Completed
Hide Studies Not Open or Pending
Condition(s):CancerLast Updated:June 11, 2010Completed
Condition(s):Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Excess Blasts in Transformation; Refractory Anemia With Ringed Sideroblasts; Secondary Myelodysplastic SyndromesLast Updated:January 24, 2013Completed
Condition(s):Central Nervous System Tumor, Pediatric; NeuroblastomaLast Updated:October 7, 2014Completed
Condition(s):Brain and Nervous System; CancerLast Updated:January 7, 2010Completed
Condition(s):Carcinoma of the Appendix; Colorectal CancerLast Updated:August 23, 2018Completed
Condition(s):Multiple MyelomaLast Updated:June 29, 2023Completed
Condition(s):Liver; CancerLast Updated:January 7, 2010Completed
Condition(s):Endometrial Adenoacanthoma; Endometrial Adenocarcinoma; Endometrial Adenosquamous Cell Carcinoma; Endometrial Clear Cell Carcinoma; Endometrial Papillary Serous Carcinoma; Recurrent Endometrial CarcinomaLast Updated:January 24, 2013Completed
Condition(s):LeukemiaLast Updated:July 2, 2010Completed
Condition(s):Advanced NsclcLast Updated:June 5, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.